EFPIA - NEWSLETTER

EFPIA Newsletter 23 February 2017

23 February 2017

News

22 February 2017 20170222 Nathalie Moll announced as new EFPIA Director General, starting in April 2017

EFPIA confirms the appointment of Nathalie Moll as its new Director General

20 February 2017 20170210 Joint Declaration on EU Industrial Strategy

Events calendar

29 MAR 2017

DIA EuroMeeting 2017 Glasgow, UK

DIA is the global forum for knowledge exchange that fosters innovation to raise the level of health and well-being worldwide...

Learn more →

28 MAR 2017

DIA BioVenture Day Glasgow, UK

Is the current Bioventure paradigm delivering return for patients and investors?" is the key question to be addressed...

Learn more →

06 JUN 2017

170609 Certificate in Healthcare Compliance Ethics & Regulation Paris, France

A whole week into the legal framework of healthcare industries

Learn more →

What we are reading

2017 European Semester: Country Reports 23 March 2017 (European Commission)

Organisation chart of the Task Force for the Preparation and Conduct of the Negotiations with... 23 February 2017 (European Commission)

How can we reduce the use of antimicrobials in food-producing animals? 23 February 2017 (EFSA-EMA)

How drug development is speeding up in the cloud 23 February 2017 (BBC)

CCMI contributes to European leadership in strategic sectors 23 February 2017 (European Economic and Social Committee)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶